HYPERINSULINISM

This adverse event was reported 107 times

HYPERINSULINISM is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN 2 0.0058
1 DIAZOXIDE 2 0.0027
2 BETAXOLOL 2 0.0024
3 BETAXOLOL HYDROCHLORIDE 1 0.0019
4 CHLOROTHIAZIDE SODIUM 1 0.0011
5 OLANZAPINE PAMOATE 35 0.0009
6 CHLOROTHIAZIDE 1 0.0008
7 ZIPRASIDONE HCL 2 0.0008
8 OLANZAPINE 42 0.0006
9 ALOGLIPTIN 2 0.0006
See all drugs enriched for association with HYPERINSULINISM

HYPERINSULINISM is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Asparagine-specific Enzyme [EPC] 2 0.0001
1 Parenteral Iron Replacement [EPC] 2 0.0001
2 Atypical Antipsychotic [EPC] 42 0.0001
3 Recombinant Human Growth Hormone [EPC] 2 0.0001
4 Barbiturate [EPC] 1 0.0001
5 Antimycobacterial [EPC] 1 0.0000
6 Interleukin-17A Antagonist [EPC] 1 0.0000
7 Protease Inhibitor [EPC] 1 0.0000
8 Serotonin Reuptake Inhibitor [EPC] 2 0.0000
9 Insulin [EPC] 1 0.0000
See all drug classes enriched for association with HYPERINSULINISM